Ofatumumab in poor-prognosis chronic lymphocytic leukemia: a Phase IV, non-interventional, observational study from the European Research Initiative on Chronic Lymphocytic Leukemia

We report the largest retrospective, phase IV non-interventional, observational study of ofatumumab therapy in heavily pre-treated patients with poor-prognosis chronic lymphocytic leukemia. Total number of patients was 103; median age was 65 years (range 39–85). Median number of prior lines of thera...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Haematologica
Main Authors: Moreno, Carol, Montillo, Marco, Panayiotidis, Panayiotis, Dimou, Maria, Bloor, Adrian, Dupuis, Jehan, Schuh, Anna, Norin, Stefan, Geisler, Christian, Hillmen, Peter, Doubek, Michael, Trněný, Marek, Obrtlikova, Petra, Laurenti, Luca, Stilgenbauer, Stephan, Smolej, Lukas, Ghia, Paolo, Cymbalista, Florence, Jaeger, Ulrich, Stamatopoulos, Kostas, Stavroyianni, Niki, Carrington, Patrick, Zouabi, Hamadi, Leblond, Veronique, Gomez-Garcia, Juan C., Rubio, Martin, Marasca, Roberto, Musuraca, Gerardo, Rigacci, Luigi, Farina, Lucia, Paolini, Rossella, Pospisilova, Sarka, Kimby, Eva, Bradley, Colm, Montserrat, Emili
Format: Artigo
Jezik:Inglês
Izdano: Ferrata Storti Foundation 2015
Teme:
Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4380724/
https://ncbi.nlm.nih.gov/pubmed/25596264
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2014.118158
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki